Skip to main content
Top
Published in: Journal of Nuclear Cardiology 5/2021

Open Access 01-10-2021 | Computed Tomography | ORIGINAL ARTICLE

Vascular uptake on 18F-sodium fluoride positron emission tomography: precursor of vascular calcification?

Authors: Annemarie M. den Harder, MD, PhD, Jelmer M. Wolterink, PhD, Jonas W. Bartstra, MD, Wilko Spiering, MD, PhD, Sabine R. Zwakenberg, MSc, Joline W. Beulens, PhD, Riemer H. J. A. Slart, MD, PhD, Gert Luurtsema, PhD, Willem P. Mali, MD, PhD, Pim A. de Jong, MD, PhD

Published in: Journal of Nuclear Cardiology | Issue 5/2021

Login to get access

Abstract

Background

Microcalcifications cannot be identified with the present resolution of CT; however, 18F-sodium fluoride (18F-NaF) positron emission tomography (PET) imaging has been proposed for non-invasive identification of microcalcification. The primary objective of this study was to assess whether 18F-NaF activity can assess the presence and predict the progression of CT detectable vascular calcification.

Methods and Results

The data of two longitudinal studies in which patients received a 18F-NaF PET-CT at baseline and after 6 months or 1-year follow-up were used. The target to background ratio (TBR) was measured on PET at baseline and CT calcification was quantified in the femoral arteries at baseline and follow-up. 128 patients were included. A higher TBR at baseline was associated with higher calcification mass at baseline and calcification progression (β = 1.006 [1.005-1.007] and β = 1.002 [1.002-1.003] in the studies with 6 months and 1-year follow-up, respectively). In areas without calcification at baseline and where calcification developed at follow-up, the TBR was .11–.13 (P < .001) higher compared to areas where no calcification developed.

Conclusion

The activity of 18F-NaF is related to the amount of calcification and calcification progression. In areas where calcification formation occurred, the TBR was slightly but significantly higher.
Appendix
Available only for authorised users
Literature
1.
go back to reference Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res. 2016;118:535–46.CrossRef Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res. 2016;118:535–46.CrossRef
2.
go back to reference Mori H, Torii S, Kutyna M, Sakamoto A, Finn AV, Virmani R. Coronary artery calcification and its progression: What does it really mean? JACC Cardiovasc Imaging. 2018;11:127–42.CrossRef Mori H, Torii S, Kutyna M, Sakamoto A, Finn AV, Virmani R. Coronary artery calcification and its progression: What does it really mean? JACC Cardiovasc Imaging. 2018;11:127–42.CrossRef
3.
go back to reference Pugliese G, Iacobini C, Blasetti Fantauzzi C, Menini S. The dark and bright side of atherosclerotic calcification. Atherosclerosis. 2015;238:220–30.CrossRef Pugliese G, Iacobini C, Blasetti Fantauzzi C, Menini S. The dark and bright side of atherosclerotic calcification. Atherosclerosis. 2015;238:220–30.CrossRef
5.
go back to reference Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM, et al. Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology. J Am Coll Cardiol. 2012;59:1539–48.CrossRef Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM, et al. Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology. J Am Coll Cardiol. 2012;59:1539–48.CrossRef
6.
go back to reference Li Y, Berenji GR, Shaba WF, Tafti B, Yevdayev E, Dadparvar S. Association of vascular fluoride uptake with vascular calcification and coronary artery disease. Nucl Med Commun. 2012;33:14–20.CrossRef Li Y, Berenji GR, Shaba WF, Tafti B, Yevdayev E, Dadparvar S. Association of vascular fluoride uptake with vascular calcification and coronary artery disease. Nucl Med Commun. 2012;33:14–20.CrossRef
7.
go back to reference Oliveira-Santos M, Castelo-Branco M, Silva R, Gomes A, Chichorro N, Abrunhosa A, et al. Atherosclerotic plaque metabolism in high cardiovascular risk subjects - A subclinical atherosclerosis imaging study with (18)F-NaF PET-CT. Atherosclerosis. 2017;260:41–6.CrossRef Oliveira-Santos M, Castelo-Branco M, Silva R, Gomes A, Chichorro N, Abrunhosa A, et al. Atherosclerotic plaque metabolism in high cardiovascular risk subjects - A subclinical atherosclerosis imaging study with (18)F-NaF PET-CT. Atherosclerosis. 2017;260:41–6.CrossRef
8.
go back to reference Nakahara T, Narula J, Strauss HW. NaF uptake in unstable plaque: What does fluoride uptake mean? Eur J Nucl Med Mol Imaging. 2018;45:2250–2.CrossRef Nakahara T, Narula J, Strauss HW. NaF uptake in unstable plaque: What does fluoride uptake mean? Eur J Nucl Med Mol Imaging. 2018;45:2250–2.CrossRef
9.
go back to reference Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JL, Dweck MR, et al. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun. 2015;6:7495.CrossRef Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JL, Dweck MR, et al. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun. 2015;6:7495.CrossRef
10.
go back to reference Plomp AS, Toonstra J, Bergen AA, van Dijk MR, de Jong PT. Proposal for updating the Pseudoxanthoma Elasticum classification system and a review of the clinical findings. Am J Med Genet A. 2010;152A:1049–58.CrossRef Plomp AS, Toonstra J, Bergen AA, van Dijk MR, de Jong PT. Proposal for updating the Pseudoxanthoma Elasticum classification system and a review of the clinical findings. Am J Med Genet A. 2010;152A:1049–58.CrossRef
11.
go back to reference Kranenburg G, de Jong PA, Bartstra JW, Lagerweij SJ, Lam MG, Ossewaarde-van Norel J, et al. Etidronate for prevention of ectopic mineralization in patients with Pseudoxanthoma elasticum. J Am Coll Cardiol. 2018;71:1117–26.CrossRef Kranenburg G, de Jong PA, Bartstra JW, Lagerweij SJ, Lam MG, Ossewaarde-van Norel J, et al. Etidronate for prevention of ectopic mineralization in patients with Pseudoxanthoma elasticum. J Am Coll Cardiol. 2018;71:1117–26.CrossRef
12.
go back to reference Zwakenberg SR, de Jong PA, Bartstra JW, van Asperen R, Westerink J, de Valk H, et al. The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: A randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2019;110(4):883–90.CrossRef Zwakenberg SR, de Jong PA, Bartstra JW, van Asperen R, Westerink J, de Valk H, et al. The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: A randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2019;110(4):883–90.CrossRef
13.
go back to reference Jenkins WS, Vesey AT, Shah AS, Pawade TA, Chin CW, White AC, et al. Valvular (18)F-fluoride and (18)F-fluorodeoxyglucose uptake predict disease progression and clinical outcome in patients with aortic stenosis. J Am Coll Cardiol. 2015;66:1200–1.CrossRef Jenkins WS, Vesey AT, Shah AS, Pawade TA, Chin CW, White AC, et al. Valvular (18)F-fluoride and (18)F-fluorodeoxyglucose uptake predict disease progression and clinical outcome in patients with aortic stenosis. J Am Coll Cardiol. 2015;66:1200–1.CrossRef
14.
go back to reference Ishiwata Y, Kaneta T, Nawata S, Hino-Shishikura A, Yoshida K, Inoue T. Quantification of temporal changes in calcium score in active atherosclerotic plaque in major vessels by (18)F-sodium fluoride PET/CT. Eur J Nucl Med Mol Imaging. 2017;44:1529–37.CrossRef Ishiwata Y, Kaneta T, Nawata S, Hino-Shishikura A, Yoshida K, Inoue T. Quantification of temporal changes in calcium score in active atherosclerotic plaque in major vessels by (18)F-sodium fluoride PET/CT. Eur J Nucl Med Mol Imaging. 2017;44:1529–37.CrossRef
15.
go back to reference Creager MD, Hohl T, Hutcheson JD, Moss AJ, Schlotter F, Blaser MC, et al. (18)F-fluoride signal amplification identifies microcalcifications associated with atherosclerotic plaque instability in positron emission Tomography/Computed tomography images. Circ Cardiovasc Imaging. 2019;12:e007835.CrossRef Creager MD, Hohl T, Hutcheson JD, Moss AJ, Schlotter F, Blaser MC, et al. (18)F-fluoride signal amplification identifies microcalcifications associated with atherosclerotic plaque instability in positron emission Tomography/Computed tomography images. Circ Cardiovasc Imaging. 2019;12:e007835.CrossRef
16.
go back to reference Derlin T, Toth Z, Papp L, Wisotzki C, Apostolova I, Habermann CR, et al. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: A dual-tracer PET/CT study. J Nucl Med. 2011;52:1020–7.CrossRef Derlin T, Toth Z, Papp L, Wisotzki C, Apostolova I, Habermann CR, et al. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: A dual-tracer PET/CT study. J Nucl Med. 2011;52:1020–7.CrossRef
17.
go back to reference Blomberg BA, Thomassen A, de Jong PA, Lam MGEH, Hess S, Olsen MH, et al. Reference values for fluorine-18-fluorodeoxyglucose and fluorine-18-sodium fluoride uptake in human arteries: A prospective evaluation of 89 healthy adults. Nucl Med Commun. 2017;38:998–1006.CrossRef Blomberg BA, Thomassen A, de Jong PA, Lam MGEH, Hess S, Olsen MH, et al. Reference values for fluorine-18-fluorodeoxyglucose and fluorine-18-sodium fluoride uptake in human arteries: A prospective evaluation of 89 healthy adults. Nucl Med Commun. 2017;38:998–1006.CrossRef
18.
go back to reference Blomberg BA, de Jong PA, Thomassen A, Lam MGE, Vach W, Olsen MH, et al. Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: Results of the CAMONA study. Eur J Nucl Med Mol Imaging. 2017;44:249–58.CrossRef Blomberg BA, de Jong PA, Thomassen A, Lam MGE, Vach W, Olsen MH, et al. Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: Results of the CAMONA study. Eur J Nucl Med Mol Imaging. 2017;44:249–58.CrossRef
19.
go back to reference Narula N, Dannenberg AJ, Olin JW, Bhatt DL, Johnson KW, Nadkarni G, et al. Pathology of peripheral artery disease in patients with critical limb ischemia. J Am Coll Cardiol. 2018;72:2152–63.CrossRef Narula N, Dannenberg AJ, Olin JW, Bhatt DL, Johnson KW, Nadkarni G, et al. Pathology of peripheral artery disease in patients with critical limb ischemia. J Am Coll Cardiol. 2018;72:2152–63.CrossRef
20.
go back to reference Torii S, Mustapha JA, Narula J, Mori H, Saab F, Jinnouchi H, et al. Histopathologic characterization of peripheral arteries in subjects with abundant risk factors: Correlating imaging with pathology. JACC Cardiovasc Imaging. 2018;12(8 Pt 1):1501–13.PubMed Torii S, Mustapha JA, Narula J, Mori H, Saab F, Jinnouchi H, et al. Histopathologic characterization of peripheral arteries in subjects with abundant risk factors: Correlating imaging with pathology. JACC Cardiovasc Imaging. 2018;12(8 Pt 1):1501–13.PubMed
21.
go back to reference Bartstra JW, de Jong PA, Spiering W. Accelerated peripheral vascular aging in Pseudoxanthoma elasticum - proof of concept for arterial calcification-induced cardiovascular disease. Aging (Albany NY). 2019;11:1062–4.CrossRef Bartstra JW, de Jong PA, Spiering W. Accelerated peripheral vascular aging in Pseudoxanthoma elasticum - proof of concept for arterial calcification-induced cardiovascular disease. Aging (Albany NY). 2019;11:1062–4.CrossRef
22.
go back to reference Niskanen L, Siitonen O, Suhonen M, Uusitupa MI. Medial artery calcification predicts cardiovascular mortality in patients with NIDDM. Diabetes Care. 1994;17:1252–6.CrossRef Niskanen L, Siitonen O, Suhonen M, Uusitupa MI. Medial artery calcification predicts cardiovascular mortality in patients with NIDDM. Diabetes Care. 1994;17:1252–6.CrossRef
23.
go back to reference Fernandez-Friera L, Penalvo JL, Fernandez-Ortiz A, Ibanez B, Lopez-Melgar B, Laclaustra M, et al. Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: The PESA (progression of early subclinical atherosclerosis) study. Circulation. 2015;131:2104–13.CrossRef Fernandez-Friera L, Penalvo JL, Fernandez-Ortiz A, Ibanez B, Lopez-Melgar B, Laclaustra M, et al. Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: The PESA (progression of early subclinical atherosclerosis) study. Circulation. 2015;131:2104–13.CrossRef
24.
go back to reference Rutten A, Isgum I, Prokop M. Coronary calcification: Effect of small variation of scan starting position on agatston, volume, and mass scores. Radiology. 2008;246:90–8.CrossRef Rutten A, Isgum I, Prokop M. Coronary calcification: Effect of small variation of scan starting position on agatston, volume, and mass scores. Radiology. 2008;246:90–8.CrossRef
25.
go back to reference Hoffmann U, Siebert U, Bull-Stewart A, Achenbach S, Ferencik M, Moselewski F, et al. Evidence for lower variability of coronary artery calcium mineral mass measurements by multi-detector computed tomography in a community-based cohort–consequences for progression studies. Eur J Radiol. 2006;57:396–402.CrossRef Hoffmann U, Siebert U, Bull-Stewart A, Achenbach S, Ferencik M, Moselewski F, et al. Evidence for lower variability of coronary artery calcium mineral mass measurements by multi-detector computed tomography in a community-based cohort–consequences for progression studies. Eur J Radiol. 2006;57:396–402.CrossRef
Metadata
Title
Vascular uptake on 18F-sodium fluoride positron emission tomography: precursor of vascular calcification?
Authors
Annemarie M. den Harder, MD, PhD
Jelmer M. Wolterink, PhD
Jonas W. Bartstra, MD
Wilko Spiering, MD, PhD
Sabine R. Zwakenberg, MSc
Joline W. Beulens, PhD
Riemer H. J. A. Slart, MD, PhD
Gert Luurtsema, PhD
Willem P. Mali, MD, PhD
Pim A. de Jong, MD, PhD
Publication date
01-10-2021
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 5/2021
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-020-02031-5

Other articles of this Issue 5/2021

Journal of Nuclear Cardiology 5/2021 Go to the issue